"PSPA is aware as many as 50% of people living with PSP & CBD are initially misdiagnosed with similar neurodegenerative conditions such as Parkinson’s. We will monitor the healthcare plans to restart, remobilise and rehabilitation will not make this shocking statistic worse and that people with PSP & CBD receive appropriate and timely care."
Scotland Country Manager, Gill Dickson, shares how PSPA has been busy keeping PSP & CBD a priority with policy and decision makers, during the COVID-19 crisis.